The Gilead Sciences Research Scholars Program in Solid Tumors – US 2026 supports early-career investigators conducting innovative research in solid tumors, with the goal of advancing scientific understanding and improving treatment approaches for patients with cancer.
The program provides independent research support for projects focused on areas including breast cancer, endometrial cancer, ovarian cancer, and small cell lung cancer. The award is designed to help promising researchers develop their careers while generating new insights into cancer biology, therapeutic strategies, and patient outcomes.
Eligibility Criteria
- Applicants must hold an MD, PhD, MD/PhD, or equivalent degree.
- Applicants must be early-career investigators.
- Applicants must hold a faculty position or equivalent research appointment.
- Applicants must have an independent research project relevant to solid tumors.
- Applicants who are not citizens or permanent residents of the United States may apply if they conduct research at an eligible U.S. institution.
Funding Details
- Funding: $180,000 per award
- Duration: 2 years
Deadline
- Letter of Intent deadline: November 13, 2026
- Full application deadline: January 2027
- Award notifications: Spring 2027
Further Information
- The program encourages research that may contribute to improved understanding, diagnosis, prevention, or treatment of cancer.
- Applicants should submit proposals through the official online application system.
- Research projects should be investigator-initiated and independent of Gilead-sponsored clinical development programs.
- Official Gilead Sciences Research Scholars Program